Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eric A Thim"'
Autor:
Lydia E. Kitelinger, Eric A. Thim, Sarah Y. Zipkowitz, Richard J. Price, Timothy N. J. Bullock
Publikováno v:
Cells, Vol 13, Iss 16, p 1317 (2024)
For triple-negative breast cancer (TNBC), the most aggressive subset of breast cancer, immune cell infiltrates have prognostic implications. The presence of myeloid-derived suppressor cells supports tumor progression, while tumor-infiltrating lymphoc
Externí odkaz:
https://doaj.org/article/aa5a4bdc6f914f908470640c4638c63f
Autor:
Hideo Yagita, Richard J Price, Natasha D Sheybani, Timothy N J Bullock, Alexandra R Witter, Eric A Thim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Triple-negative breast cancer (TNBC) remains recalcitrant to most targeted therapy approaches. However, recent clinical studies suggest that inducing tumor damage can render TNBC responsive to immunotherapy. We therefore tested a strategy
Externí odkaz:
https://doaj.org/article/3f42d182755e4cda815a615b392309f2
Autor:
Lydia E Petricca, Alexandra R Witter, Natasha D Sheybani, Eric A Thim, Timothy N Bullock, Richard J Price
Publikováno v:
The Journal of Immunology. 208:117.14-117.14
Immunologic rejection of triple-negative breast cancer (TNBC) is rare. Focused Ultrasound (FUS) promotes anti-tumor immunity by inducing tissue destruction and inflammation. We hypothesized that thermally-ablative FUS (tFUS) would increase the immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0059179cfd297da76b6ff8d19b9de945
https://doi.org/10.4049/jimmunol.208.supp.117.14
https://doi.org/10.4049/jimmunol.208.supp.117.14
Autor:
Kitelinger, Lydia E.1 (AUTHOR) lep2gw@virginia.edu, Thim, Eric A.2 (AUTHOR) eat4nh@virginia.edu, Zipkowitz, Sarah Y.1 (AUTHOR) szipkow1@binghamton.edu, Price, Richard J.2 (AUTHOR) rjp2z@virginia.edu, Bullock, Timothy N. J.1 (AUTHOR) rjp2z@virginia.edu
Publikováno v:
Cells (2073-4409). Aug2024, Vol. 13 Issue 16, p1317. 22p.
Publikováno v:
Women's Health Weekly; 8/27/2024, p1256-1256, 1p